What insurance usually covers, what it does not, and how we handle the approval for you.
Coverage, approval and your cost
Part 1 of 7
Insurance is complicated. We handle it.
We accept most insurance, including Medicare, Medicaid and Tricare. Coverage for these treatments still varies a great deal.
There are many insurance companies, and each one sells many different plans with different rules. That is hard for anyone to sort out alone.
So we do it for you.
The evidence
FDA labeling / guidelines
Coverage criteria for TMS and Spravato are set plan by plan. Most require prior authorization, which is the plan’s review of medical necessity before treatment starts.
Part 2 of 7
What we do for you.
We collect the information your plan asks for and submit the request. This step is called prior authorization.
If the plan says no, we file the appeal. We keep you updated along the way.
Once it is approved, our insurance coordinators email you the payments we expect you to owe, as accurately as we can estimate them. You know your cost before you start.
The evidence
FDA labeling / guidelines
Approved treatment can still carry a deductible, a copay or coinsurance under the terms of the plan. An estimate depends on what the plan reports at the time and can change if the plan’s information changes.
Part 3 of 7
TMS for depression: covered by most plans.
Most plans cover TMS for depression, including Medicare, when their conditions are met.
The usual condition is that you have tried several antidepressants without enough benefit. Some plans also ask about talk therapy.
The evidence
FDA labeling / guidelines
TMS has been FDA-cleared for major depressive disorder since 2008. Medicare and TRICARE cover it for adults with treatment-resistant depression under defined clinical criteria, and commercial plans set their own.
Most plans cover Spravato. They usually require that you have tried two or more antidepressants, and some ask for three or four.
Some plans also want to see that an add-on medicine was tried first, such as lithium, an antipsychotic medicine or thyroid hormone. Others do not. Each plan is different.
Many plans have a copay, coinsurance or deductible. We tell you the expected amount before you begin.
The evidence
FDA labeling / guidelines
Spravato is FDA-approved for treatment-resistant depression in adults, which the trials defined as an inadequate response to at least two antidepressants in the current episode. Plans may add requirements of their own.
Insurance does not cover ketamine for psychiatric treatment, whether it is given by infusion or by injection.
The reason is that ketamine is not FDA-approved for depression. That is not a judgment about whether it is safe or whether it works.
Ketamine was already an old, generic medicine when its effect on depression was discovered, so no company has paid for the large trials that FDA approval requires.
The evidence
FDA labeling / guidelines
Ketamine is FDA-approved as an anesthetic. It is not approved for any psychiatric disorder, and its use for depression is off-label. Esketamine, one of the two forms of the ketamine molecule, went through the approval trials and is the approved product.
TMS for OCD is FDA-cleared, but it is newer, and many plans have not caught up yet.
Some plans cover it and many do not. When coverage is possible, we get the prior authorization for you.
The evidence
FDA labeling / guidelines
TMS was first cleared for OCD in 2018. As of 2025, the manufacturer of our system reported that Medicare, Medicaid and several large commercial payers did not yet cover TMS for OCD.
Before we apply, give us the clearest record you can of the medicines you have tried.
For each one, we need the name, the dose, how long you took it, and why you stopped. Your pharmacy or your past prescribers can often print this for you.
The more detail we send, the fewer questions the plan sends back.
The evidence
FDA labeling / guidelines
Prior authorization criteria usually specify the number of antidepressant trials, an adequate dose and duration for each, and sometimes augmentation or psychotherapy. Incomplete histories are a common reason for delay or denial.
1 of 7
Coverage at a glance
TMS for depressionMost plansAfter several antidepressants have been tried
SpravatoMost plansAfter two or more antidepressants; a copay often applies
TMS for OCDSome plansNewer clearance; many plans have not caught up
Maintenance TMSRarelyA few plans cover it, sometimes on request
KetamineSelf-payNot FDA-approved for depression, so plans do not cover it
A general picture. We check your own plan before you start.
How approval works
YouShare your treatment history
WeSubmit the request to your plan
Your planReviews it
WeAppeal if it is denied
WeEmail you the expected cost
YouStart treatment
Bring or send us
Your insurance card, front and back
Each antidepressant: name, dose, how long, why stopped
Add-on medicines and therapy you have tried
Your cost
You know it before you start.
Our insurance coordinators email you the expected payments once your plan approves. Current prices for self-pay treatments are on our New patients page, or call us.
This guide is general information, not a statement of your benefits. Coverage depends on your plan, and plans change. We confirm yours before treatment.
The takeaway
Most plans cover TMS for depression and Spravato once their conditions are met. Ketamine is self-pay.
We submit the prior authorization, file any appeal, and keep you updated.
We email you your expected cost before you start.
What you can do next
Write down each antidepressant you have tried: name, dose, how long, and why you stopped.
Have your insurance card ready, front and back.
Request a consultation, and we will check your plan.